Informações:
Falhas:
ID
14286
Descrição
Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101); ODM derived from: https://clinicaltrials.gov/show/NCT00306163
Link
https://clinicaltrials.gov/show/NCT00306163
Palavras-chave
Versões (1)
- 07/04/2016 07/04/2016 -
Titular dos direitos
CC BY-NC 3.0
Transferido a
7 de abril de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Asthma NCT00306163
Eligibility Asthma NCT00306163
- StudyEvent: Eligibility
Similar models
Eligibility Asthma NCT00306163
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
history of bronchial asthma
Item
history of bronchial asthma
boolean
C0004096 (UMLS CUI [1])
fev1
Item
fev1 > 1.20 l
boolean
C0748133 (UMLS CUI [1])
positive skin prick test
Item
positive skin prick test
boolean
C0430561 (UMLS CUI [1])
fluticasone propionate
Item
not more than 500 mcg/day fluticasone propionate or equivalent for at least 28 days prior to baseline visit
boolean
C0117996 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
exclusion criteria
Item
main exclusion criteria:
boolean
C0680251 (UMLS CUI [1])
clinically relevant abnormal laboratory values
Item
clinically relevant abnormal laboratory values
boolean
C1254595 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,2])
concomitant severe diseases, diseases expected to interfere with the outcome of the study and diseases which are contra-indications for the use of inhaled steroids
Item
concomitant severe diseases, diseases expected to interfere with the outcome of the study and diseases which are contra-indications for the use of inhaled steroids
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0586793 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C0009488 (UMLS CUI [2,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0586793 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C0009488 (UMLS CUI [2,3])
copd or other relevant lung diseases
Item
chronic obstructive pulmonary disease (copd) and /or other relevant lung diseases
boolean
C0024117 (UMLS CUI [1,1])
C0024115 (UMLS CUI [1,2])
C0024115 (UMLS CUI [1,2])
asthma exacerbation
Item
one asthma exacerbation within 2 months or more than 3 exacerbations within the last year prior to baseline visit
boolean
C0349790 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
smoking history
Item
current smokers or ex-smokers with more than 10 pack years, or having smoked within 1 year prior to baseline visit
boolean
C1519384 (UMLS CUI [1])
C1277691 (UMLS CUI [2])
C1277691 (UMLS CUI [2])
saline challenge
Item
positive response to saline challenge at baseline visits
boolean
bronchial hyperresponsiveness
Item
positive bronchial hyperresponsiveness
boolean
C0085129 (UMLS CUI [1])